Phase 2 Readout
IMVT: Phase 2 Readout: imvt-1402
December 31, 2026 · imvt-1402. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2026
- Company
- Immunovant, Inc. (IMVT)
- Drug
- imvt-1402
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: imvt-1402
- Company
- Immunovant, Inc. (IMVT)
- Drug
- imvt-1402
- Indication
- Difficult-to-Treat Rheumatoid Arthritis (D2T RA)